The Opportunity:

We are seeking a highly motivated and experienced professional to join our team as a Medical Lead (ML) for gastrointestinal and pancreatic cancers (GI). This role will include to develop and execute strategic medical plan including evidence generation, publication, congress activities; engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights; serve as a therapeutic expert and thought partner to internal teams; liaison between Revolution Medicines and clinical study sites/investigators; and organize medical education, advisory boards, and medical congress activities.  

Reporting to the Director, Medical Affairs, GI, Medical Lead is an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. ML will serve as a key strategic person between Revolution Medicines and healthcare professionals in collaboration with the MSL team. Within assigned geographic territory, ML will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases of product development.  The individual will collaborate with stakeholders within medical affairs and across the organization, including but not limited to Clinical Development, Commercial, Program Management, Clinical Operations, and Compliance teams. The ideal candidate is an effective communicator, driven, detail-oriented, proactive, and a skilled collaborator. 

Key Responsibilities: 

• Develop and execute Japan Medical Affairs strategy and tactical plans for GI region including evidence generation, publication, congress activities, and so on, tailored to Japan. 

• Establish and maintain trusted scientific relationships with key opinion leaders (KOLs), investigators, and healthcare professionals across Japan.

• Provide medical oversight and scientific input to cross-functional teams, ensuring alignment with regulatory and compliance standards.

• Contribute to medical input in promotional and non-promotional materials, internal training, and advisory boards.

• Plan and execute medical meetings, education, symposia, and congress participation to enhance scientific visibility.

• Lead and support investigator-initiated trials and local clinical research activities in collaboration with global and regional teams.

• Monitor the competitive and scientific landscape to inform internal strategy and provide actionable medical insights.

• Partner with HEOR and market access to develop real-world evidence and outcomes research projects.

• Ensure compliance with Japanese data privacy regulations and educate team members.

• Collaborate closely with Clinical Operations and CROs, including site selection, Site Initiation Visits, and investigator engagement.

• Provide scientific review to ensure medical accuracy in materials developed by cross‑functional teams, including non‑promotional content and internal scientific training.

Required Education, Experience and Skills: 

• Minimum 7 years of experience in Medical Affairs or related functions in the pharmaceutical or biotech industry.

• Strong understanding of oncology clinical development, evidence generation, treatment landscape, and strategic planning.

• Proven ability to analyze and synthesize scientific information effectively.

• Experience engaging with healthcare professionals, academic researchers, and medical societies with compliance rules.

• Excellent interpersonal, organizational, and presentation skills.

• Fluency in Japanese and business level English.

• Ability to work effectively in a matrixed, cross-functional, and multicultural environment.

• Experience leading or supporting investigator-initiated or real-world evidence studies.

• Willingness to travel up to 20% of time.

Preferred Education, Experience and Skills: 

• Advanced scientific or medical degrees (MD, RPh, Ns, PhD, MPh, or MS) preferred.

• Preferred experience in Gastrointestinal and Pancreatic cancers, and product launch in Japan.

• Track record in publication planning, congress presentations, and scientific communications.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.

#LI-RY1 #LI-Hybrid